Doctor and researcher Claudia Pinto Marques Souza Oliveira, Associate Professor in the Department of Gastroenterology of the Faculdade de Medicina da Universidade de São Paulo (FMUSP), at the invitation of the Economist Intelligence Unit (The Economist Group), was part of a global commission that discussed public health policies to improve the diagnosis and treatment of non-alcoholic fatty liver disease (NAFLD) worldwide.
The doctor from the Hospital das Clínicas of FMUSP participated in a select group, composed of 55 renowned and most influential personalities in the area, internationally recognized for their medical and scientific contribution. In a series of workshops, the experts explored the opportunities and challenges to raise the disease’s profile on a national and regional scale and global health policy agendas, with a focus on Latin America, Asia-Pacific and the Middle East - regions with a high prevalence of the disease.
The joint initiative for the prevention and treatment of NAFLD at the three levels of care (primary, secondary and tertiary) was the largest ever carried out in the world.
To put the problem in perspective, NAFLD, a silent disease, impacts about 25% of the adult population worldwide, with prospects of increasing in both developed and emerging countries. About one in five people living with the disease develops fibrosis, which can lead to cirrhosis, liver cancer, terminal liver disease and death. About 51% of people are obese.
In the end, a report was prepared and published in March 2021 by The Economist Intelligence Unit, which outlines widely relevant actions that could assist in the formulation of global public health policies.
Read the publication at: https://eiuperspectives.economist.com/healthcare/nafld-sounding-alarm-global-public-health-challenge
Prof. Claudia Oliveira, who represented Brazil, has dedicated her academic professional career to liver diseases, especially to the treatment of patients with non-alcoholic fatty liver disease.